The ROE as of September 2024 (TTM) for NovAccess Global Inc. (XSNX) is 25.43%

According to NovAccess Global Inc.’s latest financial reports and current stock price. The company's current ROE is 25.43%. This represents a change of 360.51% compared to the average of 5.52% of the last 4 quarters.

NovAccess Global Inc. (XSNX) Historical ROE (quarterly & annually)

How has XSNX ROE performed in the past?

The mean historical ROE of NovAccess Global Inc. over the last ten years is 73.56%. The current 25.43% ROE has changed -65.43% with respect to the historical average. Over the past ten years (40 quarters), XSNX's ROE was at its highest in in the September 2020 quarter at 207.72%. The ROE was at its lowest in in the September 2018 quarter at -60.98%.

NovAccess Global Inc. (XSNX) ROE by Quarter and Year

Discovering the peaks and valleys of NovAccess Global Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NovAccess Global Inc. (XSNX) Average ROE

How has XSNX ROE performed in the past?

The current ROE of NovAccess Global Inc. (XSNX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NovAccess Global Inc. (XSNX) ROE vs. Peers

How is XSNX’s ROE compared to its peers?

NovAccess Global Inc.’s ROE is less than Novo Nordisk A/S (87.50%), greater than Cellectis S.A. (-81.02%), greater than Biotron Limited (-592.92%), greater than Covalon Technologies Ltd. (-4.23%), greater than Bioasis Technologies Inc. (0%), less than Mosaic ImmunoEngineering Inc. (13.27%), less than EPIRUS Biopharmaceuticals, Inc. (0%), greater than ImmunoCellular Therapeutics, Ltd. (0%), less than VG Life Sciences Inc. (2.01%), greater than Genenta Science S.p.A. (-50.79%), greater than Lumos Pharma, Inc. (-157.99%), greater than Marker Therapeutics, Inc. (-78.91%), greater than Exicure, Inc. (-288.03%), greater than Protagenic Therapeutics, Inc. (-238.37%), greater than PMV Pharmaceuticals, Inc. (-21.96%),

Build a custom stock screener for NovAccess Global Inc. (XSNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovAccess Global Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NovAccess Global Inc. (XSNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NovAccess Global Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.